Isfahan University of Medical Sciences

Science Communicator Platform

Share By
Designing and Generating a Single-Chain Fragment Variable (Scfv) Antibody Against Il2rα (Cd25): An in Silico and in Vitro Study Publisher



Navabi P1 ; Ganjalikhany MR2 ; Jafari S2 ; Dehbashi M3 ; Ganjalikhanihakemi M1
Authors

Source: Iranian Journal of Basic Medical Sciences Published:2021


Abstract

Objective(s): IL-2Rα plays a critical role in maintaining immune function. However, expression and secretion of CD25 in various malignant disorders and autoimmune diseases are now well established. Thus, CD25 is considered an important target candidate for antibody-based therapy. This study aimed to find the most suitable linker peptide to construct a functional anti-CD25 single-chain fragment variable (scFv) by bioinformatics studies and its production in a bacterial expression system. Materials and Methods: Here, the 3D structures of the scFvs with different linkers were predicted and molecular dynamics simulation was performed to compare their structures and dynamics. Then, interactions between five models of scFv and human CD25 were calculated via molecular docking. According to MD and docking results, the anti-CD25 scFvs with (Gly4Ser)3 linker were constructed and cloned into pET-22b(+). Then, recombinant plasmids were transformed into Escherichia coli Bl21 (DE3) for expression using IPTG and lactose as inducers. Anti-CD25 scFv was purified from the periplasm and detected by SDS-PAGE and Western blot. Afterward, functionality was evaluated using ELISA. Results: In silico analysis showed that the model containing (Gly4Ser)3 as a linker has more stability compared with other linkers. The results of SDS-PAGE, Western blot, and ELISA confirmed the accuracy of anti-CD25 scFv production and its ability to bind to the human CD25. Conclusion: Conclusively, our work provides a theoretical and experimental basis for production of an anti-CD25 scFv, which may be applied for various malignant disorders and autoimmune diseases. © 2021 Mashhad University of Medical Sciences. All rights reserved.
Related Docs
View other Related Docs
1. Production of a Recombinant Anti-Human Cd4 Single-Chain Variable-Fragment Antibody Using Phage Display Technology and Its Expression in Escherichia Coli, Journal of Microbiology and Biotechnology (2011)
2. Construction and Periplasmic Expression of a Bispecific Tandem Scfv for Dual Targeting of Immune Checkpoints, Advanced Biomedical Research (2023)
3. Discovery of Novel Rarα Agonists Using Pharmacophore-Based Virtual Screening, Molecular Docking, and Molecular Dynamics Simulation Studies, PLoS ONE (2023)
Experts (# of related papers)
View all Related Experts
Vajihe Akbari (4)
Hamid Mirmohammad Sadeghi (4)
Other Related Docs
4. Functional Expression of a Single-Chain Antibody Fragment Against Human Epidermal Growth Factor Receptor 2 (Her2) in Escherichia Coli, Journal of Industrial Microbiology and Biotechnology (2014)
5. Optimization of a Single-Chain Antibody Fragment Overexpression in Escherichia Coli Using Response Surface Methodology, Research in Pharmaceutical Sciences (2015)
6. In Silico Investigation of Critical Binding Pattern in Sars-Cov-2 Spike Protein With Angiotensin-Converting Enzyme 2, Scientific Reports (2021)
7. An in Silico Investigation on the Binding Site Preference of Pd-1 and Pd-L1 for Designing Antibodies for Targeted Cancer Therapy, PLoS ONE (2024)
8. In Silico Designing and Optimization of Anti-Epidermal Growth Factor Receptor Scaffolds by Complementary-Determining Regions-Grafting Technique, Quantitative Biology (2024)
9. In Silico Design of Two Novel Fusion Proteins, P28-Il-24 and P28-M4, Targeted to Breast Cancer Cells, Research in Pharmaceutical Sciences (2020)
10. Improvement of Solubility and Yield of Recombinant Protein Expression in E. Coli Using a Two-Step System, Research in Pharmaceutical Sciences (2019)
11. In Silico Designing Breast Cancer Peptide Vaccine for Binding to Mhc Class I and Ii: A Molecular Docking Study, Computational Biology and Chemistry (2016)
12. The Evaluation of Tlyp-1-Bound Mda-7/Il-24 Killing Activity on a Liver Tumor Cell Line, Cancer Biotherapy and Radiopharmaceuticals (2021)
13. Different Aspects in Explaining How Mutations Could Affect the Binding Mechanism of Receptor Binding Domain of Sars-Cov-2 Spike Protein in Interaction With Ace2, PLoS ONE (2023)
14. A Novel Car Expressing Nk Cell Targeting Cd25 With the Prospect of Overcoming Immune Escape Mechanism in Cancers, Frontiers in Oncology (2021)
15. Theoretical Design of a New Chimeric Protein for the Treatment of Breast Cancer, Research in Pharmaceutical Sciences (2016)
16. Insights Into the Human A1 Adenosine Receptor From Molecular Dynamics Simulation: Structural Study in the Presence of Lipid Membrane, Medicinal Chemistry Research (2015)
17. Computational Design of a Potential Therapeutic Peptide Against Spike Protein of Sars-Cov-2, Journal of Computational Biophysics and Chemistry (2021)
18. Designing a New Bispecific Tandem Single-Chain Variable Fragment Antibody Against Tumor Necrosis Factor-Α and Interleukin-23 Using in Silico Studies for the Treatment of Rheumatoid Arthritis, Journal of Molecular Modeling (2020)
19. Investigation of the Mutated Antimicrobial Peptides to Inhibit Ace2, Tmprss2 and Grp78 Receptors of Sars-Cov-2 and Angiotensin Ii Type 1 Receptor (At1r) As Well As Controlling Covid-19 Disease, Journal of Biomolecular Structure and Dynamics (2025)
20. Computational Study for Suppression of Cd25/Il-2 Interaction, Biological Chemistry (2021)